CytoMed Therapeutics Ltd

NASDAQ:GDTC   3:59:40 PM EDT
3.41
-0.19 (-5.28%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)37.30M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.13 Million
Adjusted EPS-$0.06
See more estimates
10-Day MA$3.57
50-Day MA$3.80
200-Day MAN/A
See more pivots

CytoMed Therapeutics Ltd Stock, NASDAQ:GDTC

1 Commonwealth Lane, No. 08-22, One Commonwealth, Singapore, Central Singapore 149544
Singapore
Phone: +65.6250.7738
Number of Employees: 28

Description

CytoMed Therapeutics Ltd. operates as a biopharmaceutical company. It engages in the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy. The company was founded by Chee Kong Choo on March 9, 2018 and is headquartered in Singapore.